Skip to main content
. 2017 Jan 17;114(5):E707–E716. doi: 10.1073/pnas.1610383114

Fig. 1.

Fig. 1.

Effect of β-catenin deletion on ErbB2KI mammary tumorigenesis. (A) Kaplan–Meier analysis of tumor onset shows the consequences of β-catenin deletion during ErbB2KI tumorigenesis. Statistical significance determined by Student’s t test. Median tumor onsets are indicated for each cohort. (B) ErbB2 expression and loss of β-catenin expression were confirmed by immunoblot analyses. (C) β-Catenin (green) was visualized by IHF staining on paraffin-embedded end-point mammary tumors, and nuclei were visualized by DAPI staining. Images were acquired by confocal microscopy. Arrow points to the stromal component of tumors. Ctnnb1+/+ErbB2KI, n = 6; Ctnnb1fl/+ErbB2K poorly differentiated, n = 5; Ctnnb1fl/+ErbB2KI others, n = 3; Ctnnb1fl/flErbB2KI, n = 5. (Scale bar: 20 μm.)